PROVETOP

Biotinylated Human STEAP2 VLP

Catalog No: STEAP2-HB001

Species
Human
Expression System
HEK293
Tag
Biotin, His
Activity
Activity verified

Product overview

Recombinant Biotinylated Human STEAP2 VLP is expressed in HEK293 cells. It contains amino acid residues Met1-Met490 (It may have cross reaction with anti-His antibody) (UniProt accession: Q8NFT2-1).

Product Details

Molecular Aliases
PUMPCn; PCANAP1; STAMP1; STEAP 2; STMP; IPCA-1;STEAP2; IPCA1
Protein Length
Met1-Met490
Expression System
HEK293
Theoretical Molecular Weight
The target protein has a predicted MW of 66.72 kDa.
Purity
> 95% as determined by HPLC
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Supplied as 0.22 μm filtered solution in PBS, 300mM L-arginine (pH 7.4).
State
Liquid
Storage Conditions
Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Data Display

SEC-HPLC
STEAP2-HB001 SEC-HPLC result

The purity of Biotinylated Human STEAP2 VLP is greater than 95% as determined by SEC-HPLC.

ELISA
STEAP2-HB001 ELISA result

Immobilized Biotinylated Human STEAP2 VLP at 5μg/ml (100μl/well) on the streptavidin precoated plate (5μg/ml). Dose response curve for Anti-STEAP2 Antibody, hFc Tag with the EC50 of 10.9ng/ml determined by ELISA. (QC Test)

Background

STEAP2, also known as the six transmembrane protein of prostate 1 (STAMP1), is located on chromosome 7q21.13, contains 6 exons and 5 introns, and encodes for a 490 aa long protein with an estimated molecular weight of 56.1 kDa. STEAP2 has been suggested to play a role in protein sorting and secretory pathways, as it shuttles to the Golgi organelle and trans-Golgi network. STEAP2 is significantly overexpressed in prostate cancer when compared to normal healthy tissue.

References

  1. Jones LA, Conway GE, Nguyen-Chi A, Burnell S, Jenkins GJ, Conlan RS, Doak SH. Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer. Cell Mol Biol (Noisy-le-grand). 2023 Apr 30;69(4):179-187. doi: 10.14715/cmb/2023.69.4.28. PMID: 37329528.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support